Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-20 3:00 pm Sale | 2022-12-31 | 13G | HAEMONETICS CORP HAE | BlackRock Inc. BLK | 5,898,620 11.700% | -793,726![]() (-11.86%) | Filing History |
| 2022-10-11 10:07 am Purchase | 2022-09-30 | 13G | HAEMONETICS CORP HAE | VANGUARD GROUP INC | 5,195,195 10.120% | 314,259![]() (+6.44%) | Filing History |
| 2022-04-08 11:19 am Purchase | 2022-04-11 | 13G | HAEMONETICS CORP HAE | Capital Research Global Investors | 5,452,006 10.700% | 3,402,873![]() (+166.06%) | Filing History |
| 2022-02-14 2:29 pm Purchase | 2021-12-31 | 13G | HAEMONETICS CORP HAE | NEUBERGER BERMAN GROUP LLC | 3,876,521 7.590% | 1,043,472![]() (+36.83%) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | HAEMONETICS CORP HAE | Capital Research Global Investors | 2,049,133 4.000% | -726,503![]() (-26.17%) | Filing History |
| 2022-02-10 08:16 am Purchase | 2021-12-31 | 13G | HAEMONETICS CORP HAE | VANGUARD GROUP INC | 4,880,936 9.550% | 28,654![]() (+0.59%) | Filing History |
| 2022-02-10 07:48 am Purchase | 2022-01-31 | 13G | HAEMONETICS CORP HAE | WELLINGTON MANAGEMENT GROUP LLP | 5,537,538 10.830% | 447,237![]() (+8.79%) | Filing History |
| 2022-02-04 09:27 am Purchase | 2021-12-31 | 13G | HAEMONETICS CORP HAE | WELLINGTON MANAGEMENT GROUP LLP | 5,090,301 9.960% | 2,837,909![]() (+126.00%) | Filing History |
| 2022-01-26 8:18 pm Unchanged | 2021-12-31 | 13G | HAEMONETICS CORP HAE | BlackRock Inc. BLK | 6,692,346 13.100% | 0 (Unchanged) | Filing History |
| 2022-01-25 11:15 am Purchase | 2021-12-31 | 13G | HAEMONETICS CORP HAE | BlackRock Inc. BLK | 6,692,346 13.100% | 713,043![]() (+11.93%) | Filing History |
| 2021-07-09 6:05 pm Purchase | 2021-06-30 | 13G | HAEMONETICS CORP HAE | BlackRock Inc. BLK | 5,979,303 11.700% | 1,278,712![]() (+27.20%) | Filing History |
| 2021-06-10 11:46 am Sale | 2021-06-10 | 13G | HAEMONETICS CORP HAE | Capital Research Global Investors | 2,775,636 5.400% | -2,862,099![]() (-50.77%) | Filing History |

